Sinclair Pharma plc

Notification and public disclosure of transactions by persons dischargingmanagerial responsibilities and persons closely associated with them

London, 17 January 2018Sinclair Pharma plc (AIM:SPH.L) ('Sinclair' or the 'Group'), the international aesthetics company, was advised on 16 January 2018, that on that day, Jeff Thompson, Non-Executive Director, acquired 200,000 ordinary shares of 1p each ('Ordinary Shares') in the Group at an average price of 23.1p per Ordinary Share.

Following these purchases, Jeff Thompson's total beneficial interest is 350,000 Ordinary Shares, 0.07% of the issued share capital of the Group.

For further information please contact:

Sinclair Pharma plc

Tel: +44 (0) 20 7467 6920

Chris Spooner

Alan Olby

Andy Crane

Peel Hunt LLP (NOMAD and Joint Broker)

Tel: +44 (0) 20 7418 8900

James Steel

Oliver Jackson

RBC Capital Markets (Joint Broker)

Tel: +44 (0) 20 7653 4000

Marcus Jackson

Laura White

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jeff Thompson

2.

Reason for the notification

a.

Position/status

Non-Executive Director

b.

Initial notification

/Amendment

Initial Announcement

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Sinclair Pharma plc

b.

LEI

213800BNMD7JVMHW1772

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary Shares of 1 pence each in Sinclair Pharma plc

GB0033856740

b.

Nature of the transaction

Purchase

c.

Price(s) and volume(s)

Price(s)

Volume(s)

23.1p

200,000

d.

Aggregated information

· Aggregated volume· Price

N/A

e.

Date of the transaction

2018-01-16

f.

Place of the transaction

London Stock Exchange, AIM

Sinclair Pharma plc published this content on 17 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 17 January 2018 10:49:09 UTC.

Original documenthttp://ir1.euroinvestor.com/asp/ir/SinclairISPharma/NewsRead.aspx?storyid=13782605&ishtml=1

Public permalinkhttp://www.publicnow.com/view/CB3662DE2210BAF4B4137BA8979B5D8CAF6BB7A3